In breast cancer, GATA6 can stimulate EMT by inhibiting the E‐cadherin protein.15 Strong expression of GATA6 is associated with liver metastasis and poor patient survival in CRC.16 However, the role of miR‐944 and its correlation with GATA6 in CRC have not been reported clearly. Here, GATA6 is linked to colorectal carcinoma.